160 related articles for article (PubMed ID: 34863091)
1. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
[TBL] [Abstract][Full Text] [Related]
2. miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis of colorectal cancer through targeting S100A4.
Chengling L; Yulin Z; Xiaoyu X; Xingchen L; Sen Z; Ziming W; Xianming C
Mol Med; 2021 Mar; 27(1):23. PubMed ID: 33691630
[TBL] [Abstract][Full Text] [Related]
3. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer.
Qian J; Gong ZC; Zhang YN; Wu HH; Zhao J; Wang LT; Ye LJ; Liu D; Wang W; Kang X; Sheng J; Xu W; Liu XL; Wu J; Zheng W
Cell Commun Signal; 2021 Jan; 19(1):9. PubMed ID: 33478523
[TBL] [Abstract][Full Text] [Related]
4. CCL7 playing a dominant role in recruiting early OCPs to facilitate osteolysis at metastatic site of colorectal cancer.
Yang H; Jian L; Jin Q; Xia K; Cai-Ru W; Jun S; Chen H; Wei W; Ben-Jing S; Shi-Hong L; Shi-Wei L; Juan W; Wei Z
Cell Commun Signal; 2022 Jun; 20(1):94. PubMed ID: 35715847
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF/ERK/CCL3 pathway.
Zi-Chen G; Jin Q; Yi-Na Z; Wei W; Xia K; Wei X; Juan W; Wei Z
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478376
[TBL] [Abstract][Full Text] [Related]
6. GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer.
Jian L; Shi-Wei L; Dan J; Juan W; Wei Z
J Orthop Surg Res; 2023 Jan; 18(1):3. PubMed ID: 36593458
[TBL] [Abstract][Full Text] [Related]
7. miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65.
Chen L; Wang Y; Lu X; Zhang L; Wang Z
Front Cell Dev Biol; 2021; 9():681968. PubMed ID: 34485279
[TBL] [Abstract][Full Text] [Related]
8. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.
Yang C; Davis JL; Zeng R; Vora P; Su X; Collins LI; Vangveravong S; Mach RH; Piwnica-Worms D; Weilbaecher KN; Faccio R; Novack DV
Cancer Discov; 2013 Feb; 3(2):212-23. PubMed ID: 23269702
[TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
[No Abstract] [Full Text] [Related]
11. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
[TBL] [Abstract][Full Text] [Related]
12. Increase in the Number of Bone Marrow Osteoclast Precursors at Different Skeletal Sites, Particularly in Long Bone and Jaw Marrow in Mice Lacking IL-1RA.
Ascone G; Cao Y; Jansen IDC; Di Ceglie I; van den Bosch MHJ; Blom AB; van Lent PLEM; Everts V; de Vries TJ
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471111
[TBL] [Abstract][Full Text] [Related]
13. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
Marino S; Bishop RT; Mollat P; Idris AI
Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
[TBL] [Abstract][Full Text] [Related]
18. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
[TBL] [Abstract][Full Text] [Related]
19. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
Furugaki K; Moriya Y; Iwai T; Yorozu K; Yanagisawa M; Kondoh K; Fujimoto-Ohuchi K; Mori K
Clin Exp Metastasis; 2011 Oct; 28(7):649-59. PubMed ID: 21688034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]